Important Tips on How You Can Participate in a Mesothelioma Clinical Trial

Vital Tips on How You Can Participate in a Mesothelioma Clinical Trial

A clinical trial is a process that all new treatment options and medications go through before they are accepted and registered for general usage. These trials often offer a last hope for cure for many terminal and hard diseases. Most drugs that have become standard therapies for many illnesses today have all undergone an extensive period of testing with clinical trials.

There are three stages of clinical trials. Phase I trials enroll a limited number of people. They normally center on the right dosage and relative safety of a particular drug. Phase II trials enroll more people and are used to determine if the new drug really works against a particular illness. Phase III trials are the final phase before a drug is approved for treating a disease. During Phase III, the new drug is compared against the existing treatment. The goal during Phase III is to prove the new drug is a more effective treatment.

To find about clinical trials you can participate in you can check on the internet for resources that list ongoing clinical trials for mesothelioma, which include the qualifications for each.

You can also consult your mesothelioma doctor for information on available clinical trials. Doctors have access to all upcoming and current clinical trials, and can also help determine if a patient qualifies for a particular trial.

You can also contact the large regional cancer centers in their area, which will have access to information on clinical trials being coordinated from their hospitals

You have to consider a lot of factors if you want to take part in a clinical trial. Clinical trials typically occur in large metropolitan hospitals and it is vital to know how often participants will need to see the physicians coordinating the trials and how long each visit will take, these visits will translate into a lot of hotel and travel expenses.

Not everyone qualifies for a clinical trial, different trials use different criteria for selecting eligible participants. Some clinical trials want participants that that have undergone an unsuccessful traditional treatment, while other clinical trials want patients who have not been treated at all.

Another factor that you have to consider about clinical trial is that you will have no control over the kind of treatment you will receive. In randomized clinical trials, patients receive the traditional treatment while others receive the experimental treatment. You do not get to choose which treatment you receive, nor will you know what treatment is being administered. There is no guarantee that a participant will receive the experimental treatment.

Despite apparent risks, the benefits of clinical trials are numerous. Without clinical trials it would be nearly impossible to judge the effectiveness of new drugs. The health care that participants receive during a clinical trial is fantastic. Careful records must be kept and extensive testing must be done to gauge the effectiveness and safety of a new therapy.

Mesothelioma is an aggressive form of asbestos cancer with an extremely low survival rate and clinical trials are one of the best ways to find a cure. The patients currently involved in mesothelioma clinical trials will hopefully pave the way for a more effective treatment. You must consult with your doctor about the various available clinical trials once you are diagnosed with mesothelioma.

Mesothelioma Treatment Centers www.mesorc.com Mesothelioma is a rare form of cancer, representing less than 1 percent of all cancer types, or about 2500 and 3000 people in the United States annually. This means that smaller medical centers rarely see or treat patients with the disease. In addition, diagnosis and treatment of this cancer can be hard. For these reasons, it’s vital for patients suffering from mesothelioma to be treated at centers with the proper level of expertise. We’ve made a list of established medical centers in the United States that have programs and physicians who specialize in mesothelioma, usually as part of a division or center dedicated to thoracic diseases. These are meant as a centralized resource, not as a ranking or an endorsement of the care facilities. Descriptions of each treatment center are adapted from the facility’s website and include links back to additional resources. NORTHEAST Brigham and Women’s Hospital Dana-Farber Cancer Institute Fox Chase Cancer Center Hospital of the University of Pennsylvania Massachusetts General Hospital Memorial Sloan-Kettering Cancer Center Mount Sinai Medical Center Norris Cotton Cancer Center NYU Langone Medical Center Yale Cancer Center SOUTHEAST Duke University Medical Center Emory Winship Cancer Institute H. Lee Moffitt Cancer Center and Research Institute Johns Hopkins Hospital Markey Cancer Center and the University of Kentucky MUSC Hollings Cancer Center University of Alabama Hospital …

4 Major Factors to Consider When You Want to Participate in a Mesothelioma Clinical Trial

4 Major Factors to Consider When You Want to Participate in a Mesothelioma Clinical Trial

Clinical trials for new mesothelioma treatments give hope for the discovery of a possible cure for the deadly cancer. Mesothelioma is an aggressive form of asbestos related cancer with a very high mortality rate, most victims die within 1-2 years after the diagnosis. The patients currently involved in mesothelioma clinical trials will hopefully lead to the discovery of better and more efficient ways of treating the disease. Consulting with a physician about various available clinical trials should be considered at the initial diagnosis.

A clinical trial is a process that new treatment options and medications pass through before they are approved for use by the general population. Many patients with terminal diseases are advised to participate in clinical trials as a last hope for a cure. Many drugs and therapies that become the standard therapy of care for many diseases have gone through an extensive period of testing with clinical trials before they were approved for general use.

Factors to Consider Before Taking Part in a Clinical Trial There are a variety of factors to take into consideration when considering participation in a clinical trial.

1- The distance to the trial center and the financial implications of taking part in the clinical trial

Clinical trials most times take place in large metropolitan hospitals located in the major cities, some of the patients but live in smaller towns far from these major cities. It is vital to know how often participants will need to see the physicians coordinating the trials and how long each visit will take, and how much the hotel and travel expenses will likely cost.

2- Selection criteria for the trial

Not everyone qualifies for a clinical trial ,the criteria for selection for a particular drug trial varies. Some clinical trials will want patients that have tried using some other medication which did not work, while other clinical trials require that the participating patients have not started any treatment for their disease.

3- The risk factor

Another factor when considering a clinical trial is the loss of control over medical treatment. In some clinical trials, referred to as randomized studies, patients receive the traditional treatment while others receive the experimental treatment. The patient does not choose which treatment they receive, nor do they likely know what treatment is being administered. There is no guarantee that a participant will receive the experimental treatment. There is always a risk involved in using experimental drugs and treatments, they might have unknown side effects that will only show up when they are used by human beings.

4- General state of health of the patient

A patient’s general health is also a major consideration when preparing to participate in a clinical trial. Patients with other pre-existing medical disease will not be allowed to participate in most clinical trials as well as patients on other major medications. The presence of other medical diseases might affect the accuracy and reliability of the results of the clinical trials. Some of those other major medications might also interact negatively with the actions of the drugs that are on trial.